Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OOKYO Pharma Ltd

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

OKYO Pharma Ltd

$1.35Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Fiscal 2026Mar 31, 2026
Fiscal 2025Mar 31, 2025
Fiscal 2024Mar 31, 2024
Fiscal 2023Mar 31, 2023
Fiscal 2022Mar 31, 2022
Fiscal 2021Mar 31, 2021
The costs of running the business beyond making or delivering its products, such as research, marketing, and office expenses.
+19.8% YoY-55.0% YoY+19.4% YoY+112.1% YoY+84.7% YoY+119.3% YoY
Profit before income taxes are taken out.Formula: Operating income + net non-operating income + pre-tax adjustments
-12.2% YoY+52.6% YoY-26.5% YoY-113.7% YoY-84.0% YoY-108.5% YoY
The income tax cost counted against the period’s profit, including amounts payable now or later.
-98.4% YoY+3046.8% YoY-67.2% YoY
The profit left after all expenses and taxes. A negative number means the company lost money.Formula: Total income − total expenses
-90.2% YoY+72.0% YoY-26.8% YoY-144.4% YoY-62.0% YoY-117.2% YoY
Profit for each ordinary share during the reporting period.Formula: Earnings available to common shareholders ÷ weighted-average basic shares
-100.0% YoY+78.9% YoY+6.6% YoY-69.4% YoY-12.5% YoY
Profit per share after counting potential extra shares from stock awards or convertible securities that would reduce it.Formula: Diluted earnings available to common shareholders ÷ weighted-average diluted shares
-100.0% YoY+78.9% YoY+6.6% YoY-69.4% YoY-12.5% YoY